A groundbreaking blood test developed by Leeds-based PinPoint Data Science is poised to significantly alter the way the NHS diagnoses potential womb cancer. By leveraging advanced artificial intelligence, this innovative test could spare thousands of women from undergoing painful and invasive procedures, marking a new era in women’s health care.
A Painful Procedure No More
Each year, approximately 90,000 postmenopausal women in England are referred by their general practitioners due to concerns over heavy bleeding, which can signal the presence of womb cancer. While around 10,000 women are diagnosed with this form of cancer annually, the associated diagnostic process often involves a transvaginal ultrasound scan—a procedure that many find uncomfortable and distressing.
The PinPoint blood test, undergoing trials at various NHS trusts, has shown the potential to eliminate the need for this invasive examination in about 18,000 cases each year. This is particularly crucial, given that roughly 20% of women referred for assessment do not have cancer. Under the current system, all women referred must undergo a pelvic examination, and if cancer is still suspected, further invasive procedures such as biopsies and hysteroscopies may follow.
Proven Efficacy from Extensive Trials
The test’s introduction follows an extensive study involving 16,481 patients referred from 170 GP practices across Yorkshire for nine different types of cancer. Among these, 3,313 women were specifically evaluated for womb cancer due to their symptoms. The findings of the trial were impressive, revealing an accuracy rate of 99% in both identifying and ruling out the presence of gynaecological cancers.
Mid Yorkshire NHS teaching trust is among the first to adopt the PinPoint test, intending to use it for diagnosing six forms of gynaecological cancer and upper gastrointestinal cancers. Additionally, the Leeds Teaching Hospitals NHS Trust plans to implement the test for gynaecological cancer assessments.
A New Approach to Cancer Screening
The PinPoint test employs machine learning algorithms to evaluate an individual’s risk of cancer by analysing 30 different blood markers. Prof Sean Duffy, the chief medical officer at PinPoint and a former NHS England national clinical director for cancer, emphasised the remarkable accuracy of the test. He stated, “Its value lies in safely ruling out very low-risk women, potentially sparing thousands from painful invasive procedures.”
Dr Jacinta Walsh, a general practitioner at King’s Medical Practice in Normanton, West Yorkshire, highlighted the efficiency this test could introduce into the diagnostic process. “It often takes up to six visits to a GP before we’re able to rule out cancer,” she noted. “PinPoint will help shortcut that process to deliver peace of mind earlier and free up our capacity to see other patients.”
Brent Kilmurray, chief executive of the Mid Yorkshire trust, echoed the sentiment, asserting that there is a strong case for hospitals to adopt the test in their cancer detection protocols. Consultant gynaecologist Tracy Jackson at the Leeds trust added, “If we can confidently rule out low-risk women in primary care, we reduce unnecessary invasive procedures and shorten our waiting lists.”
Optimism from Cancer Research UK
Cancer Research UK has also expressed enthusiasm regarding the PinPoint test, with spokesperson Samantha Harrison describing it as “promising.” She remarked, “Spotting cancer early saves lives, but right now patients are not being diagnosed quickly enough. This test could help to rule out endometrial cancer in some women through a simple blood test, without the need for further testing.”
Harrison emphasised the necessity for more research to fully comprehend the benefits for both patients and the NHS, but the initial results are indeed encouraging.
Why it Matters
The introduction of this AI-powered blood test represents a significant leap forward in the realm of women’s health, particularly in the accurate and timely diagnosis of womb cancer. By reducing the need for painful procedures, it not only enhances the quality of care for patients but also optimises the resources within the NHS. As healthcare continues to evolve, innovations like the PinPoint test exemplify how technology can transform patient experiences, alleviate unnecessary anxiety, and ultimately save lives.